Ashapura Minechem [ASHAPURMIN] vs Chemo-Pharma [CPL] Detailed Stock Comparison

Ashapura Minechem

NSE
Loading...

Chemo-Pharma

BSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Ashapura Minechem wins in 9 metrics, Chemo-Pharma wins in 10 metrics, with 0 ties. Chemo-Pharma appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricAshapura MinechemChemo-PharmaBetter
P/E Ratio (TTM)17.4112.19Chemo-Pharma
Price-to-Book Ratio4.872.57Chemo-Pharma
Debt-to-Equity Ratio95.1344.70Chemo-Pharma
PEG Ratio0.230.62Ashapura Minechem
EV/EBITDA15.7313.91Chemo-Pharma
Profit Margin (TTM)10.24%11.11%Chemo-Pharma
Operating Margin (TTM)11.09%9.62%Ashapura Minechem
EBITDA Margin (TTM)11.09%9.62%Ashapura Minechem
Return on Equity24.20%20.97%Ashapura Minechem
Return on Assets (TTM)7.53%11.26%Chemo-Pharma
Free Cash Flow (TTM)$-2.12B$41.66MChemo-Pharma
1-Year Return104.00%-14.96%Ashapura Minechem
Price-to-Sales Ratio (TTM)1.791.42Chemo-Pharma
Enterprise Value$70.84B$4.67BAshapura Minechem
EV/Revenue Ratio2.101.60Chemo-Pharma
Gross Profit Margin (TTM)68.75%29.30%Ashapura Minechem
Revenue per Share (TTM)$356$51Ashapura Minechem
Earnings per Share (Diluted)$36.46$5.66Ashapura Minechem
Beta (Stock Volatility)0.570.23Chemo-Pharma
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Ashapura Minechem vs Chemo-Pharma Stock Performance Analysis

Loading Price Chart...

Ashapura Minechem
Chemo-Pharma
Ashapura Minechem Stock Overview | Chemo-Pharma Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Ashapura Minechem-2.25%11.62%23.87%63.72%102.70%57.11%
Chemo-Pharma-0.31%0.53%-3.11%-6.82%-13.51%-41.33%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Ashapura Minechem104.00%593.99%676.81%1,209.91%1,113.48%811.72%
Chemo-Pharma-14.96%317.31%141.95%667.49%1,232.62%1,232.62%

News Based Sentiment: Ashapura Minechem vs Chemo-Pharma

Ashapura Minechem

News based Sentiment: POSITIVE

Ashapura Minechem demonstrated strong financial performance in September with its maiden earnings call and positive share price movement. While analyst opinions are mixed and institutional holdings slightly decreased, the overall narrative is positive, driven by robust Q1 results and a commitment to shareholder returns. This suggests continued growth potential, making it a significant month for investors.

View Ashapura Minechem News Sentiment Analysis

Chemo-Pharma

News based Sentiment: NEUTRAL

The month saw share price fluctuations and a discrepancy in reported market capitalization, but no major strategic shifts or financial results were announced. These developments are noteworthy but don't fundamentally alter the investment outlook.

View Chemo-Pharma News Sentiment Analysis

Performance & Financial Health Analysis: Ashapura Minechem vs Chemo-Pharma

MetricASHAPURMINCPL
Market Information
Market Cap i₹59.26B₹4.08B
Market Cap CategoryMid capSmall cap
10 Day Avg. Volume i1,211,00335,247
90 Day Avg. Volume i803,55334,367
Last Close₹620.35₹68.02
52 Week Range₹200.45 - ₹645.00₹66.00 - ₹128.00
% from 52W High-3.82%-46.86%
All-Time High₹645.00 (Sep 15, 2025)₹128.00 (Jan 06, 2025)
% from All-Time High-3.82%-46.86%
Growth Metrics
Quarterly Revenue Growth0.90%0.08%
Quarterly Earnings Growth0.84%0.34%
Financial Health
Profit Margin (TTM) i0.10%0.11%
Operating Margin (TTM) i0.11%0.10%
Return on Equity (TTM) i0.24%0.21%
Debt to Equity (MRQ) i95.1344.70
Cash & Liquidity
Book Value per Share (MRQ)₹130.39₹26.86
Cash per Share (MRQ)₹12.72₹1.01
Operating Cash Flow (TTM) i₹1.64B₹277.99M
Levered Free Cash Flow (TTM) i₹2.96B₹313.23M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i₹0.00₹0.00

Valuation & Enterprise Metrics Analysis: Ashapura Minechem vs Chemo-Pharma

MetricASHAPURMINCPL
Price Ratios
P/E Ratio (TTM) i17.4112.19
Forward P/E iN/AN/A
PEG Ratio i0.230.62
Price to Sales (TTM) i1.791.42
Price to Book (MRQ) i4.872.57
Market Capitalization
Market Capitalization i₹59.26B₹4.08B
Enterprise Value i₹70.84B₹4.67B
Enterprise Value Metrics
Enterprise to Revenue i2.101.60
Enterprise to EBITDA i15.7313.91
Risk & Other Metrics
Beta i0.570.23
Book Value per Share (MRQ) i₹130.39₹26.86

Financial Statements Comparison: Ashapura Minechem vs Chemo-Pharma

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)ASHAPURMINCPL
Revenue/Sales i₹5.55B₹697.42M
Cost of Goods Sold i₹987.47M₹493.08M
Gross Profit i₹4.56B₹204.34M
Research & Development iN/AN/A
Operating Income (EBIT) i₹550.67M₹67.12M
EBITDA i₹1.11B₹79.31M
Pre-Tax Income i₹815.09M₹55.13M
Income Tax i₹57.76M₹12.13M
Net Income (Profit) i₹785.48M₹42.99M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)ASHAPURMINCPL
Cash & Equivalents i₹1.09B₹12.05M
Total Current Assets i₹21.01B₹2.51B
Total Current Liabilities i₹17.08B₹1.17B
Long-Term Debt i₹8.58B₹109.50M
Total Shareholders Equity i₹12.23B₹1.49B
Retained Earnings iN/AN/A
Property, Plant & Equipment i₹11.82B₹144.04M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)ASHAPURMINCPL
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricASHAPURMINCPL
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i1,211,00335,247
Average Daily Volume (90 Day) i803,55334,367
Shares Outstanding i95.53M57.55M
Float Shares i48.76M17.06M
% Held by Insiders i0.51%0.70%
% Held by Institutions i0.11%0.00%

Dividend Analysis & Yield Comparison: Ashapura Minechem vs Chemo-Pharma

MetricASHAPURMINCPL
Last 12-Month Dividend i₹0.00₹0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i₹0.17₹0.00
3-Year Avg Dividend Yield i0.55%N/A
3-Year Total Dividends i₹0.50₹0.00
Ex-Dividend DateSep 21, 2022N/A